Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1674, USA.
Curr Opin Immunol. 2011 Oct;23(5):598-604. doi: 10.1016/j.coi.2011.08.003. Epub 2011 Aug 31.
Interleukin-2 (IL-2) is a pleiotropic cytokine that drives T-cell growth, augments NK cytolytic activity, induces the differentiation of regulatory T cells, and mediates activation-induced cell death. Along with IL-4, IL-7, IL-9, IL-15, and IL-21, IL-2 shares the common cytokine receptor γ chain, γ(c), which is mutated in humans with X-linked severe combined immunodeficiency. Herein, we primarily focus on the recently discovered complex roles of IL-2 in broadly modulating T cells for T helper cell differentiation. IL-2 does not specify the type of Th differentiation that occurs; instead, IL-2 modulates expression of receptors for other cytokines and transcription factors, thereby either promoting or inhibiting cytokine cascades that correlate with each Th differentiation state. In this fashion, IL-2 can prime and potentially maintain Th1 and Th2 differentiation as well as expand such populations of cells, whereas it inhibits Th17 differentiation but also can expand Th17 cells.
白细胞介素-2(IL-2)是一种多效细胞因子,可促进 T 细胞生长,增强 NK 细胞的细胞毒性,诱导调节性 T 细胞分化,并介导激活诱导的细胞死亡。与白细胞介素-4(IL-4)、白细胞介素-7(IL-7)、白细胞介素-9(IL-9)、白细胞介素-15(IL-15)和白细胞介素-21(IL-21)一样,IL-2 共享共同的细胞因子受体 γ 链(γ(c)),在 X 连锁严重联合免疫缺陷的人类中发生突变。在此,我们主要关注 IL-2 在广泛调节 T 细胞以促进辅助性 T 细胞分化方面的最新发现的复杂作用。IL-2 并不能指定发生的 Th 分化类型;相反,IL-2 调节其他细胞因子和转录因子受体的表达,从而促进或抑制与每种 Th 分化状态相关的细胞因子级联。通过这种方式,IL-2 可以启动并可能维持 Th1 和 Th2 分化以及扩增这些细胞群体,而抑制 Th17 分化,但也可以扩增 Th17 细胞。